Lytix Biopharma
Tromsø, Norway· Est. 2003
Develops oncolytic peptide immunotherapies for cancer treatment.
Private Company
Total funding raised: $18.5M
About
Develops oncolytic peptide immunotherapies for cancer treatment.
RNA & Gene Therapy
Funding History
2Total raised:$18.5M
Grant$3.5MMay 15, 2021
Series A$15MSep 15, 2020